In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

By Bharath Rajeswaran (Reuters) -Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.

Tariffs on Indian generics could raise US drug prices, disrupt supply chains, and strain insurance systems. Indian firms, ...

Vasudha Pharma Chem Limited and three employees are charged in DC court for illegally importing chemicals to produce fentanyl ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Satyanarayana Chava of Laurus Labs stated that global pharma firms prioritise sustainability, scale, and compliance over cost ...

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...